Arama Sonuçları - Ugochi Emeribe

  • Gösterilen 1 - 4 sonuçlar arası kayıtlar. 4
Sonuçları Daraltın
  1. 1
    Phase II, randomized, open-label study of durvalumab (MEDI4736) or tremelimumab monotherapy, or durvalumab + tremelimumab, in patients with recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): CONDOR

    Phase II, randomized, open-label study of durvalumab (MEDI4736) or tremelimumab monotherapy, or durvalumab + tremelimumab, in patients with recurrent or metastatic (R/M) squamous c... Yazar: Jill Gilbert, Christophe Le Tourneau, Hisham Mehanna, Jérôme Fayette, Trishna Goswami, Ugochi Emeribe, Anthony Jarkowski, Giovanni Melillo, L.L. Siu

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  2. 2
    Phase III, randomized, open-label study of durvalumab (MEDI4736) monotherapy, or durvalumab + tremelimumab, versus standard of care (SoC), in recurrent or metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): eagle

    Phase III, randomized, open-label study of durvalumab (MEDI4736) monotherapy, or durvalumab + tremelimumab, versus standard of care (SoC), in recurrent or metastatic (R/M) squamous... Yazar: Robert L. Ferris, C. Even, Robert Haddad, Makoto Tahara, Trishna Goswami, April Franks, Ugochi Emeribe, Anthony Jarkowski, Giovanni Melillo, Lisa Licitra

    Baskı/Yayın Bilgisi 2015
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  3. 3
    NXY-059 for the Treatment of Acute Ischemic Stroke

    NXY-059 for the Treatment of Acute Ischemic Stroke Yazar: Ashfaq Shuaib, Kennedy R. Lees, Patrick D. Lyden, James C. Grotta, Antonio Dávalos, Stephen M. Davis, Hans‐Christoph Diener, Tim Ashwood, Warren W. Wasiewski, Ugochi Emeribe

    Baskı/Yayın Bilgisi 2007
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:
  4. 4
    Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours

    Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours Yazar: Stan B. Kaye, Steinar Aamdal, Richard D. Jones, Gilles Freyer, Éric Pujade-Lauraine, Elisabeth G.E. de Vries, Jorge Barriuso, Shahneen Sandhu, Daniel S.W. Tan, V Hartog, Bart C. Kuenen, Rita Ruijter, Gunnar B. Kristensen, Marta Nyakas, Sophie Barrett, Wendy Burke, D Pietersma, Melissa K. Stuart, Ugochi Emeribe, Epie Boven

    Baskı/Yayın Bilgisi 2012
    Tam Metin Erişim Tam Metin Erişim
    Artigo
    Favorilerime ekle
    Kaydedildi:

Arama Araçları: